共 50 条
- [1] DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL TO EVALUATE INDUCTION OF CLINICAL RESPONSE IN PATIENTS WITH MODERATE-SEVERE CROHN'S DISEASE TREATED WITH RIFAXIMININFLAMMATORY BOWEL DISEASES, 2018, 24 : S51 - S51Lee, Scott D.Singla, AnandRulyak, Stephen J.Clark-Snustad, Kindra D.
- [2] DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL TO EVALUATE INDUCTION OF CLINICAL RESPONSE IN PATIENTS WITH MODERATE-SEVERE CROHN'S DISEASE TREATED WITH RIFAXIMINGASTROENTEROLOGY, 2018, 154 (06) : S388 - S389Lee, Scott D.Singla, AnandRulyak, Stephen J.Clark-Snustad, Kindra D.
- [3] Onercept for moderate-to-severe Crohn's disease: A randomized, double-blind, placebo-controlled trialCLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (07) : 888 - 893Rutgeerts, PaulSandborn, William J.Fedorak, Richard N.Rachmilewitz, DanielTarabar, DinoGibson, PeterNielsen, Ole HaagenWild, GarySchreiber, StefanRossi, Claudia PenaZignani, Monia
- [4] Infliximab therapy for patients with moderate to severe hidradenitis, suppurativa: A randomized, double-blind, placebo-controlled crossover trialJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (02) : 205 - 217Grant, AnnikaGonzalez, TaylerMontgomery, Michael O.Cardenas, VanessaKerdel, Francisco A.
- [5] A PHASE 1/2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF THE INDUCTION OF CLINICAL RESPONSE AND REMISSION BY QBECO IN SUBJECTS WITH MODERATE TO SEVERE CROHN'S DISEASEGASTROENTEROLOGY, 2017, 152 (05) : S600 - S600Gunn, HalSutcliffe, SimonPankovich, JimChen, Jenny M.Vandermeirsch, GillianThompson, DarbyFedorak, Richard N.Panaccione, RemoAxler, Jeffrey L.Bressler, Brian
- [6] A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitusBMC EAR NOSE AND THROAT DISORDERS, 2011, 11Suckfuell, MarkusAlthaus, MichaelEllers-Lenz, BarbaraGebauer, AlexanderGoertelmeyer, RomanJastreboff, Pawel J.Moebius, Hans J.Rosenberg, TanjaRuss, HermannWirth, YvonneKrueger, Hagen
- [7] Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trialGASTROENTEROLOGY, 2001, 121 (05) : 1088 - 1094Sandborn, WJHanauer, SBKatz, SSafdi, MWolf, DGBaerg, RDTremaine, WJJohnson, TDiehl, NNZinsmeister, AR
- [8] Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trialHEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1724 - 1729Arora, SKatkov, WCooley, JKemp, JAJohnston, DESchapiro, RHPodolsky, D
- [9] A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's DiseaseAMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (11): : 1599 - 1607Targan, Stephan R.Feagan, BrianVermeire, SeverinePanaccione, RemoMelmed, Gil Y.Landers, CarolLi, DalinRussell, ChrisNewmark, RichardZhang, NanChon, YunHsu, Yi-HsiangLin, Shao-LeeKlekotka, Paul
- [10] A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's diseaseALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 421 - 430Mansfield, J. C.Parkes, M.Hawthorne, A. B.Forbes, A.Probert, C. S. J.Perowne, R. C.Cooper, A.Zeldis, J. B.Manning, D. C.Hawkey, C. J.